Pharmacokinetics and Pharmacodynamics
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
“Pharmacokinetics and Pharmacodynamics” is a Section of the peer-reviewed open access journal Pharmaceutics, which is devoted to highlighting the importance of pharmacokinetics and pharmacodynamics in drug development for better understanding of drug action. The Section welcomes original research articles as well as review papers that address a variety of related topics to novel and significant scientific findings by in vitro, in vivo, and clinical studies. The manuscript mainly focused on descriptive pharmacokinetics lacking novelty and scientific significance will not be considered for review.
Covered topics include:
- Mechanisms and factors affecting drug absorption, distribution, metabolism, and excretion;
- Kinetics of drug disposition and therapeutic effects;
- Pharmacokinetics, pharmacodynamics, and pharmacometrics;
- Toxicokinetics and toxicodynamics;
- Mathematical model for the assessment of drug ADME;
- Model-based drug development;
- Translational mathematical modeling in drug development;
- Quantitative systems pharmacology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Drug–Drug Interactions—New Perspectives (Deadline: 10 May 2026)
- Innovations in Drug Delivery, Pharmacometrics, and Clinical Studies in Veterinary Medicine (Deadline: 31 May 2026)
- Metal Complexes as Antimicrobial Agents: Pharmacokinetics and Drug Development Implications (Deadline: 15 June 2026)
- Recent Advances in Physiologically Based Biopharmaceutics Modeling (Deadline: 25 June 2026)
- Advancing HIV Prevention and Treatment: Pharmacokinetics, Pharmacodynamics, Toxicokinetics, Formulation and Delivery of Antiretroviral Drugs (Deadline: 30 June 2026)
- Optimizing Drug Therapy in Kidney Diseases: Effectiveness and Safety (Deadline: 31 July 2026)
- Population Pharmacokinetics: Where Are We Now? (Deadline: 31 August 2026)
- Novel Research on Physiologically-Based Pharmacokinetic Modeling (Deadline: 31 August 2026)
- Model-Informed Precision Dosing in Drug Development and Clinical Practice (Deadline: 31 August 2026)
- Pharmacokinetics of Orally Administered Drugs, 3rd Edition (Deadline: 20 September 2026)
- Optimizing Drug Therapy Through Pharmacokinetics and Therapeutic Drug Monitoring (Deadline: 30 September 2026)
- Pharmacokinetic Perspectives on Drug Interactions in Therapy (Deadline: 30 September 2026)
- Population Pharmacokinetics and Its Clinical Applications, 2nd Edition (Deadline: 25 October 2026)
- Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and Applications (Deadline: 29 October 2026)
- Pathophysiological Influences on Pharmacokinetics and Pharmacodynamics, 2nd Edition (Deadline: 31 October 2026)
- Recent Advances in Physiologically Based Pharmacokinetics (Deadline: 20 November 2026)
- Advances in Pharmacokinetics of Targeted Anti-Cancer Drugs (Deadline: 30 November 2026)
- Advancing Biologic Drug Development Through Physiologically Based Pharmacokinetic Modeling and Simulations, 2nd Edition (Deadline: 30 November 2026)
- In Silico Pharmacokinetic and Pharmacodynamic (PK-PD) Modeling (Deadline: 31 December 2026)
- Model Informed Precision Dosing in Special Populations: Bridging Physiology, Models and Clinical Practice (Deadline: 31 December 2026)
- Personalized Medicine: Integrating Pharmacogenetics and Pharmacokinetics (Deadline: 31 December 2026)
- Challenges and Trends in Geriatric Pharmacotherapy: Pharmacodynamics, Pharmacokinetics, and Personalized Therapeutic Strategies (Deadline: 31 December 2026)
